A patient with hyperkalemia should avoid which diuretic due to potassium-sparing effects?

Study for the Foundation Year Pharmacy – Clinical Practice Test. Prepare with detailed questions, step-by-step explanations, and test format insights. Enhance your readiness and confidence!

Multiple Choice

A patient with hyperkalemia should avoid which diuretic due to potassium-sparing effects?

Explanation:
Potassium-sparing diuretics conserve potassium by reducing its excretion, so they can worsen hyperkalemia. Spironolactone blocks aldosterone receptors in the collecting ducts, which decreases potassium secretion and leads to potassium retention. In a patient with high potassium, this raises the risk further, so spironolactone should be avoided. The other diuretics listed promote potassium loss: hydrochlorothiazide and furosemide increase distal sodium delivery and potassium excretion, while acetazolamide causes bicarbonate diuresis with potential potassium loss.

Potassium-sparing diuretics conserve potassium by reducing its excretion, so they can worsen hyperkalemia. Spironolactone blocks aldosterone receptors in the collecting ducts, which decreases potassium secretion and leads to potassium retention. In a patient with high potassium, this raises the risk further, so spironolactone should be avoided. The other diuretics listed promote potassium loss: hydrochlorothiazide and furosemide increase distal sodium delivery and potassium excretion, while acetazolamide causes bicarbonate diuresis with potential potassium loss.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy